These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26412735)

  • 21. [Frontiers in vitamin D; basic research and clinical application. Inhibitory effects of eldecalcitol, an active vitamin D derivative, on bone resorption in vivo].
    Harada S; Mizoguchi T; Takahashi N
    Clin Calcium; 2011 Nov; 21(11):91-8. PubMed ID: 22040825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alfacalcidol increases cancellous bone in low turnover, fatty marrow sites in aged, orchidectomized rats.
    Tian XY; Chen HY; Setterberg RB; Li M; Jee WS
    J Musculoskelet Neuronal Interact; 2009; 9(3):138-46. PubMed ID: 19724148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].
    Takeuchi Y
    Clin Calcium; 2015 Mar; 25(3):425-32. PubMed ID: 25716816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
    Matsumoto T; Takano T; Yamakido S; Takahashi F; Tsuji N
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):261-4. PubMed ID: 20298784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eldecalcitol: a review of its use in the treatment of osteoporosis.
    Sanford M; McCormack PL
    Drugs; 2011 Sep; 71(13):1755-70. PubMed ID: 21902297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical markers of bone turnover. New aspect. Bone collagen metabolism: new biological markers for estimation of bone quality].
    Saito M
    Clin Calcium; 2009 Aug; 19(8):1110-7. PubMed ID: 19638694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D3 analogs for the treatment of osteoporosis.
    Hagino H
    Can J Physiol Pharmacol; 2015 May; 93(5):327-32. PubMed ID: 25853632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Elevated plasma concentration of homocysteine, low level of vitamin B6, pyridoxal, and vitamin D insufficiency in patients with hip fracture: a possible explanation for detrimental cross-link pattern in bone collagen].
    Saito M
    Clin Calcium; 2006 Dec; 16(12):1974-84. PubMed ID: 17142927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Musculoskeletal rehabilitation and bone. Mechanical stress and bone quality : do mechanical stimuli alter collagen cross-link formation in bone? "Yes" ].
    Saito M; Marumo K
    Clin Calcium; 2010 Apr; 20(4):520-8. PubMed ID: 20354325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Bone quality in chronic kidney disease : enzymatic and non-enzymatic glycation or oxidation induced cross-links in bone].
    Saito M; Marumo K
    Clin Calcium; 2010 Jul; 20(7):1068-76. PubMed ID: 20585186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alfacalcidol on back extensor strength gained through back extensor exercise in postmenopausal women with osteoporosis.
    Hara S; Kishimoto KN; Okuno H; Tanaka M; Saito H; Oizumi A; Itoi E
    Am J Phys Med Rehabil; 2013 Feb; 92(2):101-10. PubMed ID: 23044701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol.
    Kubodera N
    Mini Rev Med Chem; 2009 Oct; 9(12):1416-22. PubMed ID: 19929815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical Pharmacokinetics of Active Vitamin D3 and its derivatives, and Vitamin K2(Menatetrenone).].
    Tsugawa N
    Clin Calcium; 2016; 26(11):1547-1558. PubMed ID: 27777388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
    Sugimoto M; Futaki N; Harada M; Kaku S
    Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vitamin D and calcium for the treatment of osteoporosis].
    Inoue D
    Nihon Rinsho; 2009 May; 67(5):967-74. PubMed ID: 19432118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
    Schacht E; Dukas L; Richy F
    J Musculoskelet Neuronal Interact; 2007; 7(2):174-84. PubMed ID: 17627088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Osteoporosis in patients with diabetes mellitus].
    Yamauchi M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():526-30. PubMed ID: 18161160
    [No Abstract]   [Full Text] [Related]  

  • 38. [Active vitamin D3 analog].
    Takata S
    Nihon Rinsho; 2015 Oct; 73(10):1701-5. PubMed ID: 26529933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
    Kubodera N; Tsuji N; Uchiyama Y; Endo K
    J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Poor bone quality in diabetes and arterioscelerosis].
    Saito M
    Clin Calcium; 2009 Sep; 19(9):1257-68. PubMed ID: 19721196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.